Please assess the completion status of the following clinical trial:

Trial Title: Peri-operative rATG-perfusion of Solid Transplants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients receiving a kidney or liver transplant from deceased donors~Exclusion Criteria:~* Hepatitis C Virus/Human Immunodeficiency Virus, undergoing re-transplantation or under a public guardian

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- AP-KTx/LTx (Type: ACTIVE_COMPARATOR): Transplant recipients receiving an rATG-perfused kidney or liver
- CP-KTx/LTx (Type: PLACEBO_COMPARATOR): Transplant recipients receiving a control-perfused kidney or liver.

Based on this trial design, predict the completion outcome and termination type (if applicable).